시장 개관

Endoscopes are medical devices that allow minimally invasive procedures by inserting them through natural body openings to observe internal organs or tissues in detail. These devices are commonly used for imaging and minor surgeries.

The Endoscopy Devices Market is projected to grow from USD 33,271 백만 단위 2022 USD로 45,420 백만 단위로 2028, 복합 연간 성장률로 (CAGR) ~의 6.56% 예측 기간 동안 (2023-2028).

The increasing prevalence of chronic and other diseases is expected to drive the adoption of endoscopy for diagnostic and therapeutic purposes, thereby contributing to market growth. A study published by the British Heart Foundation (BHF) in January 2022 highlighted the global burden of cardiovascular diseases, such as coronary heart disease, peripheral arterial disease, stroke, and atrial fibrillation. The demand for endoscopy procedures for diagnostic purposes is likely to rise due to the high burden of cardiovascular diseases, 시장 성장 더욱 촉진.

게다가, the growing importance and adoption of minimally invasive surgeries worldwide have led to a steady increase in the utilization of endoscopy devices for improved patient outcomes. Minimally invasive surgery (MIS) is preferred for many abdominal and pelvic surgeries due to its benefits, including reduced morbidity and faster recovery times. The increasing adoption of MIS will drive the use of endoscopy devices for surgical monitoring purposes, thereby boosting market growth.

뿐만 아니라, manufacturers of endoscopy devices are increasingly focusing on technological advancements to develop advanced endoscopy systems, contributing to market growth. 예를 들어, FUJIFILM Healthcare launched a dual-channel endoscope approved by the United States Food and Drug Administration (FDA) for upper and lower gastrointestinal applications in November 2021. 6월 2022, Getinge released an updated version of the ED-Flow automated endoscope reprocessor with enhanced digital connectivity and data management capabilities, offering improved uptime and increased productivity.

In summary, factors such as the high prevalence of chronic diseases, 기술 발전, and product launches by market players are expected to drive significant growth in the global endoscopy devices market. 하지만, challenges related to the lack of skilled technicians and infections caused by some endoscopes may hinder market growth.

시장 세분화

시장은 다양한 요인에 따라 분류됩니다., including type of device, 애플리케이션, 및 지역.

Segmentation by Type of Device
Endoscopes – Rigid Endoscope, Flexible Endoscope, Capsule Endoscope, and Robot-assisted Endoscope – Irrigation/Suction System, Access Device, Wound Protector, Insufflation Device, Operative Manual Instrument, and Other Endoscopic Operative Devices
Visualization Equipment – Endoscopic Camera, SD Visualization System, and HD Visualization System

애플리케이션 별 세분화
Gastroenterology
Pulmonology
Orthopedic Surgery
Cardiology
ENT Surgery
Gynecology
신경학
기타 애플리케이션

지역별 세분화
북아메리카 – 미국, 캐나다, 그리고 멕시코
유럽 – 영국, 독일, 프랑스, 이탈리아, 스페인, 및 유럽의 나머지 지역
아시아 태평양 – 중국, 일본, 인도, 대한민국, 호주, 및 기타 아시아 태평양 지역
라틴 아메리카 – 브라질, 아르헨티나, 및 나머지 라틴 아메리카
중동 및 아프리카 – 남아프리카, GCC, 및 기타 중동 및 아프리카

In terms of device types, the endoscopes segment held the largest market share in 2022, amounting to USD 13,056 백만. 복합적인 연간 성장률을 경험할 것으로 예상됩니다. (CAGR) ~의 6.71% 예측 기간 동안. Within the endoscope scopes category, flexible endoscopes accounted for the majority of the segment, USD로 6,650 백만 단위 2022 and an expected CAGR of 5.86% 예측 기간 동안. A flexible endoscope is an optical instrument that transmits light and captures images for observation. These instruments are equipped with flexible transparent fibers. The flexible endoscope segment is anticipated to grow during the forecast period due to its advantages over other alternatives, increasing launches, and higher adoption rates.

The extensive use of endoscopes is necessary for diagnosing various chronic diseases such as inflammatory bowel diseases (IBD), stomach cancer, colon cancer, respiratory infections, respiratory tumors, 그리고 더. 따라서, the high prevalence of these diseases leads to a surge in demand for flexible endoscopes. 예를 들어, according to the American Cancer Society’s 2023 report, there were an estimated 26,380 new cases of stomach cancer diagnosed in the United States in 2022, with an estimated 26,500 new cases projected for 2023. 그러므로, the high incidence and prevalence of such chronic diseases drive the demand for flexible endoscopes. 추가적으로, the launch of new products and approvals by market players are expected to propel the growth of the flexible endoscope segment. An example of this is Boston Scientific receiving FDA approval for the EXALT Model B Single-Use Bronchoscope in August 2021. This bronchoscope is specifically designed for complex respiratory procedures in the ICU. 따라서, significant growth is expected in the flexible endoscope segment due to the increasing prevalence of diseases, the advantages offered by flexible endoscopes, and continuous product launches.

응용 측면에서, the gastroenterology segment held the largest market share in 2022, amounting to USD 7,486 백만, and it is expected to witness a CAGR of 5.16% 예측 기간 동안. Gastrointestinal endoscopy involves the use of a long, flexible, lighted instrument called an endoscope to examine the digestive system by inserting it either through the rectum or down through the throat. This procedure is used to evaluate and treat disorders of the esophagus, stomach, small intestine, colon, pancreas, and bile ducts. The growth of the gastroenterology segment is primarily driven by the increasing incidence of gastrointestinal diseases across all age groups. Examples of such disorders include dyspepsia, irritable bowel syndrome, and constipation. Gastroesophageal reflux disease is also a prevalent type of organic gastrointestinal disorder. The growing burden of gastrointestinal diseases, coupled with the aging population, fuels the demand for gastrointestinal endoscopy. Gastrointestinal tumors are the second leading cause of cancer-related deaths globally, and endoscopy has become the standard method for diagnosing gastrointestinal cancers. 따라서, the increasing number of endoscopic procedures for early cancer detection is expected to boost the market in the coming years, particularly for gastrointestinal stromal tumors originating in the rectum, colon, and esophagus.

지리적으로, North America dominated the market in 2022, with a market share of USD 12,785 백만, CAGR로 성장할 것으로 예상됩니다. 6.45% 예측 기간 동안. The region’s endoscopy market is driven by the high burden of diseases such as cardiovascular diseases, colorectal cancer, stomach cancer, and the increasing adoption of minimally invasive surgeries. Technological innovations, approvals, 제품 출시, and partnerships by market players also contribute to the market’s growth. 예를 들어, according to data from Cedars-Sinai updated in January 2022, coronary artery bypass graft surgery (CABG) is the most common heart surgery in the United States, 이상으로 300 thousand successful procedures performed each year. This high number of bypass surgeries may lead to increased demand for image-guided surgical systems, thereby driving the growth of endoscopy devices in the country.

뿐만 아니라, the market in North America is expected to be boosted by an increase in endoscopic procedures for early diagnosis of gastrointestinal and colorectal cancers. As per the American Cancer Society’s 2023 report, there are expected to be approximately 21.5 thousand diagnosed cases of esophagus cancer, 26.5 thousand cases of stomach cancer, 그리고 153 thousand cases of colorectal cancer in the United States in 2023. The high burden of these cancers will drive the demand for endoscopy devices in the country during the forecast period.

The region also experiences significant growth due to the continuous launches and approvals of endoscopy devices. 예를 들어, Zsquare, a developer of single-use endoscopes, received FDA 510K clearance in July 2022 to market its product, the Zsquare ENT-Flex Rhinolaryngoscope, 미국에서. 추가적으로, PENTAX Medical launched the Performance Endoscopic Ultrasound (EUS) system in Canada in November 2022. PENTAX Medical is a leading healthcare industry player in diagnostic and therapeutic endoscopy solutions.

그러므로, factors such as increasing product launches, the adoption of minimally invasive imaging and surgeries for chronic diseases, and technological advancements are expected to drive the growth of the endoscopy market in Canada during the forecast period.

경쟁 구도

The market exhibits a moderate level of competition and is populated by several prominent global players. These companies strive to establish clear differentiation in their endoscopic systems based on their specific applications. The key market players include Boston Scientific Corporation, Medtronic PLC, Olympus Corporation, Cook Group Incorporated, and Johnson & 존슨.

Key companies profiled in this report include Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, Richard Wolf GmbH, 존슨 & 존슨, 후지필름 홀딩스 주식회사, Medtronic PLC, Olympus Corporation, Karl Storz SE & 공동. 킬로그램, Stryker Corporation.

최근 산업 발전

1월 2023, AA Medical announced a strategic partnership with Certified Endoscopy Products, a reputable medical device reprocessing company based in Chicago, with expertise in endoscopic devices. 함께, AA Medical and Certified Endoscopy will establish a leading medical device reprocessing company that will cater to the needs of the endoscopy, 정형외과, and other surgical device markets.

8 월 2022, Medtronic introduced GI Genius, an innovative artificial intelligence module for endoscopy procedures aimed at addressing colorectal cancer in India. This advanced medical solution provides real-time data and empowers physicians with enhanced visualization during colonoscopy, enabling them to detect and treat colorectal cancer more effectively. The introduction of GI Genius represents a significant step forward in improving outcomes for patients with colorectal cancer through cutting-edge technology and augmented capabilities for physicians.

주요 질문에 대한 답변

What is the duration of the study period for the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market has been studied from 2018 에게 2028.

What is the growth rate of the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market is experiencing a compound annual growth rate (CAGR) ~의 6.56% 향후 5년 동안.

What is the size of the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market is projected to reach USD 33,271 백만 단위 2022 CAGR로 성장할 것으로 예상됩니다. 6.56% USD에 도달하려면 45,420 백만 단위로 2028.

Which region exhibits the highest growth rate in the Global Endoscopy Devices Market?
The Asia Pacific region demonstrates the highest CAGR between 2018 그리고 2028 in the Global Endoscopy Devices Market.

Which region holds the largest share in the Global Endoscopy Devices Market?
~ 안에 2022, North America holds the highest market share in the Global Endoscopy Devices Market.

Who are the key players operating in the Global Endoscopy Devices Market?
The major companies operating in the Global Endoscopy Devices Market include Medtronic PLC, Olympus Corporation, Cook Group Incorporated, 존슨 & 존슨, and Boston Scientific Corporation.